Abstract
The field of interventional cardiac procedures is rapidly growing. Since the “first in men” catheter-based implantation of a biological aortic valve by Cribier, the number of transcatheter based aortic replacements (TAVR) exceeds several thousand implantations per year worldwide. Beside this percutaneous treatment of mitral regurgitation (MitraClip®), closure of the left atrial appendage, and closure of a patent foramen ovale have been developed. Whereas MitraClip® procedures require general anaesthesia, percutaneous closure of the left atrial appendage as well as closure of a patent foramen ovale are usually performed without the help of anaesthesiologists and will therefore not be discussed furthermore. The transapical NeoChord DS 1000 system (NeoChord Inc, USA) is a new treatment option for patients with severe mitral regurgitation and prolapse of the posterior mitral leaflet that can be done off-pump. Keywords : interventional cardiac procedures; new innovations
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
